|4Jan 22, 9:29 PM ET

Galena Biopharma, Inc. 4

4 · Galena Biopharma, Inc. · Filed Jan 22, 2014

Insider Transaction Report

Form 4
Period: 2013-12-31
Dunlap Ryan
Principal Accounting Officer
Transactions
  • Other

    Common Stock

    2013-12-31$1.88/sh+2,728$5,1255,343 total
Footnotes (1)
  • [F1]Pursuant to the Issuer's Employee Stock Purchase Plan.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT